上海莱馥医疗科技

Life-Biotech is a clinical-stage biotechnology company headquartered in Shanghai, China, specializing in the development of advanced cell therapies. The company focuses on utilizing human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) and natural killer (NK) cells to treat a variety of inflammatory, autoimmune, and degenerative diseases. Their lead programs target indications such as systemic lupus erythematosus (SLE), COVID-19-related acute respiratory distress syndrome, and knee osteoarthritis. Life-Biotech operates integrated R&D and manufacturing facilities that comply with international standards to support its clinical pipeline. The company aims to provide innovative regenerative medicine solutions to address significant unmet medical needs globally.